JHOP - October 2024 Vol 14, No 5
Cassidy H. Padgett, PharmD, MPH; Ryan N. Shely, PharmD, BCPS; Scott T. Pierce, MD
Raluca M. Laza, PharmD; Rachel L. McDevitt, PharmD, BCOP; Mark M. Zalupski, MD
Molly Schmidt, PharmD, BCPS, BCOP, CSP; Robin Lockhorst, PharmD, BCPS, BCOP; Grant Middendorff, PharmD; Tiffani R. Kirkpatrick, PharmD
Original Research, Adverse Events, Breast Cancer, CDK4/6 Inhibitors, Oncology Pharmacy Programs/Protocols
Katelin Ivey, PharmD, BCPS; Tristan Maiers, PharmD, BCOP; Justine Maley, PharmD
Ocular Adverse Events of Antibody–Drug Conjugates Used for the Treatment of Gynecologic Malignancies
Chelsea Pragides, PharmD; Mikaylah Johnson, BS, PharmD Candidate; Sarah Hayward, PharmD, BCOP; Jennifer MacDonald, PharmD, BCOP; Erin Hickey Zacholski, PharmD, BCOP